KTR opens Bone Marrow Transplant Unit in BIACH&RI

KTR opens Bone Marrow Transplant Unit in BIACH&RI

Minister for Information Technology, Municipal Administration and Urban Development KT Rama Rao today inaugurated an advanced Bone Marrow Transplant Unit on the premises of Basavatarakam Indo American Cancer Hospital & Research Institute in the presence of Nandamuri Balakrishna, hospital chairman and other dignitaries.

The BIACH&RI has introduced Bone Marrow Transplant Unit for NOVALIS Tx Rapid Arc based Radiation Therapy, PET-CT along with Cyclotron, Gama Camera, Tomotheraphy, Robotic Surgical System and so on for the first time as part of making available world class treatment to needy cancer patients. The “Bone Marrow Transplant Unit” contains six pressurized rooms equipped with HEPA (high-e efficiency particulate air) filter systems to fully control infections. Built with advanced technology, the unit is capable of delivering world class treatment for the patients.

Speaking on the occasion, KTR lauded the efforts undertaken by BIACH&RI to fulfill the dreams of late NTR to provide affordable cancer care to the people. He also requested the hospital authorities to come up with a proposal to set up additional night shelters near the hospital for the convenience of the patients and thei attendants. He also urged Nandamuri Balakrishna to act as a brand ambassador in spreading the awareness about the disease among the common man. The minister announced that the State government would waive municipal tax for all those establishments run by various NGOs, Trusts as they are doing a lot of good work to the society.

Later, Balakrishna explained about various measures being undertaken by the hospital in order to introduce advanced technologies such as new BMT facility, Robotic Surgery and Tomotherapy to provide world class cancer care. He thanked Chief Minister K Chandrashekhar Rao for providing tax relief to the hospital.

Later, a meeting was organized where Dr RV Prabhakar Rao, CEO, BIACH&RI highlighted the achievements and facilities available in the hospital. Dr Senthil Rajappa, HoD, Medical Oncology, spoke on the need of BMT to tackle leukemia cases. Dr Senthi Rajappa has assured that the cost of treatment would be less than 40% than any other hospital in the region.

The program was attended by JSR Prasad, Trust Board Member, BIACH&RI; Dr Tulasi Devi Polavarapu, Trust Board Member, BIACH&RI; Dr. RV Prabhakar Rao, CEO, BIACH&RI; Dr. TS Rao, Medical Director; Dr Kalpana Raghunath, Medical Superintendent, Dr Senthil Rajappa, HOD, Medical Oncology along with Nandamuri Balakrishna, Chairman, BIACH&RI and a large number of staff members, patients, nursing students and others participated. (NSS)